DREADD technology reveals major impact of Gq signalling on cardiac electrophysiology. Issue 6 (13th October 2018)
- Record Type:
- Journal Article
- Title:
- DREADD technology reveals major impact of Gq signalling on cardiac electrophysiology. Issue 6 (13th October 2018)
- Main Title:
- DREADD technology reveals major impact of Gq signalling on cardiac electrophysiology
- Authors:
- Kaiser, Elisabeth
Tian, Qinghai
Wagner, Michael
Barth, Monika
Xian, Wenying
Schröder, Laura
Ruppenthal, Sandra
Kaestner, Lars
Boehm, Ulrich
Wartenberg, Philipp
Lu, Huiyan
McMillin, Sara M
Bone, Derek B J
Wess, Jürgen
Lipp, Peter - Abstract:
- Abstract: Aims: Signalling via Gq-coupled receptors is of profound importance in many cardiac diseases such as hypertrophy and arrhythmia. Nevertheless, owing to their widespread expression and the inability to selectively stimulate such receptors in vivo, their relevance for cardiac function is not well understood. We here use DREADD technology to understand the role of Gq-coupled signalling in vivo in cardiac function. Methods and results: We generated a novel transgenic mouse line that expresses a Gq-coupled DREADD (Dq) in striated muscle under the control of the muscle creatine kinase promotor. In vivo injection of the DREADD agonist clozapine-N-oxide (CNO) resulted in a dose-dependent, rapid mortality of the animals. In vivo electrocardiogram data revealed severe cardiac arrhythmias including lack of P waves, atrioventricular block, and ventricular tachycardia. Following Dq activation, electrophysiological malfunction of the heart could be recapitulated in the isolated heart ex vivo. Individual ventricular and atrial myocytes displayed a positive inotropic response and arrhythmogenic events in the absence of altered action potentials. Ventricular tissue sections revealed a strong co-localization of Dq with the principal cardiac connexin CX43. Western blot analysis with phosphor-specific antibodies revealed strong phosphorylation of a PKC-dependent CX43 phosphorylation site following CNO application in vivo . Conclusion: Activation of Gq-coupled signalling has a majorAbstract: Aims: Signalling via Gq-coupled receptors is of profound importance in many cardiac diseases such as hypertrophy and arrhythmia. Nevertheless, owing to their widespread expression and the inability to selectively stimulate such receptors in vivo, their relevance for cardiac function is not well understood. We here use DREADD technology to understand the role of Gq-coupled signalling in vivo in cardiac function. Methods and results: We generated a novel transgenic mouse line that expresses a Gq-coupled DREADD (Dq) in striated muscle under the control of the muscle creatine kinase promotor. In vivo injection of the DREADD agonist clozapine-N-oxide (CNO) resulted in a dose-dependent, rapid mortality of the animals. In vivo electrocardiogram data revealed severe cardiac arrhythmias including lack of P waves, atrioventricular block, and ventricular tachycardia. Following Dq activation, electrophysiological malfunction of the heart could be recapitulated in the isolated heart ex vivo. Individual ventricular and atrial myocytes displayed a positive inotropic response and arrhythmogenic events in the absence of altered action potentials. Ventricular tissue sections revealed a strong co-localization of Dq with the principal cardiac connexin CX43. Western blot analysis with phosphor-specific antibodies revealed strong phosphorylation of a PKC-dependent CX43 phosphorylation site following CNO application in vivo . Conclusion: Activation of Gq-coupled signalling has a major impact on impulse generation, impulse propagation, and coordinated impulse delivery in the heart. Thus, Gq-coupled signalling does not only modulate the myocytes' Ca 2+ handling but also directly alters the heart's electrophysiological properties such as intercellular communication. This study greatly advances our understanding of the plethora of modulatory influences of Gq signalling on the heart in vivo . … (more)
- Is Part Of:
- Cardiovascular research. Volume 115:Issue 6(2019)
- Journal:
- Cardiovascular research
- Issue:
- Volume 115:Issue 6(2019)
- Issue Display:
- Volume 115, Issue 6 (2019)
- Year:
- 2019
- Volume:
- 115
- Issue:
- 6
- Issue Sort Value:
- 2019-0115-0006-0000
- Page Start:
- 1052
- Page End:
- 1066
- Publication Date:
- 2018-10-13
- Subjects:
- Gq mediated signalling -- Cardiac -- Design receptor -- Pharmacogenetics -- In vivo electrophysiology
Cardiovascular system -- Diseases -- Periodicals
Cardiovascular system -- Periodicals
616.1 - Journal URLs:
- http://cardiovascres.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://www.sciencedirect.com/science/journal/00086363 ↗ - DOI:
- 10.1093/cvr/cvy251 ↗
- Languages:
- English
- ISSNs:
- 0008-6363
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3051.490000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 14199.xml